$ 0.5807 <%= Resources.Global.txtDown %>
Updated 14/12/2018
Change % -4.58% Stock price decreasing
Change -0.0279 Stock price decreasing
Volume 736,964
High $ 0.6268
Low $ 0.5710
Open $ 0.6200
ISIN
Prev close $ 0.6086
# of shares 82.32M
Market cap 47.81M USD
Intraday

Market closed
Trevena Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  0.58 -10.3% Stock price decreasing -9.3% Stock price decreasing -64.2% Stock price decreasing -66.8% Stock price decreasing -64.8% Stock price decreasing
Powered by TradingView

News about Trevena Inc

  • English
  • Regulatory news
13 Dec
 
12 Dec
 
10 Dec
 
10 Dec
 
10 Dec
 
10 Dec
 
09 Dec
 
07 Dec
 
06 Dec
 
06 Dec
 

Company profile

Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain.

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
17 December 2018 08:22:45
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20181207.1 - EUROWEB4 - 2018-12-17 09:22:45 - 2018-12-17 08:22:45 - 1000 - Website: OKAY